Pages

Showing posts with label acting out. Show all posts
Showing posts with label acting out. Show all posts

Tuesday, December 5, 2017

Sleep, Discipline and Childhood Behavioral Disorders




A couple of news stories about some new “studies” recently caught my eye. They illustrate the downright ungodly lengths certain segments of the mental health industry, as well as dope-dealing drug companies like Shire Pharmaceuticals, will go to distract both the field and the public from the real cause of many childhood behavioral problems: family interactions. They do so in order to justify their mostly ineffective and potentially toxic treatments. 

The stories were:

1    1. Poor Childhood Sleep May Lead to Behavior Woes in Adolescence by Molly Walker, Staff Writer, MedPage Today, December 04, 2017: Study suggests bidirectional association for some problems

“Young children who had greater sleep problems were more likely to have certain types of behavioral problems years later, Australian researchers found…There was a bidirectional association between sleep problems and externalizing difficulties, such as attention deficit-hyperactivity disorder, oppositional defiant disorder, and conduct disorder, in children when measured at particular time points through early adolescence, reported Jon L. Quach, PhD, of the University of Melbourne in Australia…Quach's group said that the directionality of the associations between sleep problems in children and later behavioral problems are "poorly understood," but argued that "addressing this knowledge gap will provide valuable information to inform the focus and timing of interventions aiming to improve children's sleep and behavior during the elementary school years...Sleep problems were defined by parent report. 

Of course they relied on parental reporting - to make use of parental denial to the maximum extent possible. 

“The directionality of the associations between sleep problems in children and later behavioral problems are ‘poorly understood?’” Poorly understood, my ass. See below.

       2.  ADHD and insomnia appear intertwined By: Bruce Jancin, Clinical Psychiatry News, November 30, 2017  (http://www.mdedge.com/clinicalpsychiatrynews/article/153175/adhd/adhd-and-insomnia-appear-intertwined?oc_slh=b7663e08a51cd61023636ca0354888a37f5bd7dbaf016b90aac8a66134946998&channel=296&utm_source=News_CPN_eNL_120417_F&utm_medium=email&utm_content=Self-harm+on+rise+in+U.S.+among+this+group)

“Converging evidence suggests that attention-deficit/hyperactivity disorder and sleep difficulties share a common underlying etiology involving circadian rhythm disturbance, J.J. Sandra Kooij, MD, PhD, declared at the annual congress of the European College of Neuropsychopharmacology…Having built the case for circadian disruption as an underlying cause of both ADHD symptoms and the commonly comorbid sleep problems…Multiple studies have shown that roughly 75% of children and adults with ADHD have sleep-onset insomnia.”


Shared etiology for sleep problems and certain childhood behavioral disorders like ADHD? Well, duh. Both are caused by parents who don't know how to discipline their kids. In the case of ADHD, they let them stay up half the night playing video games. And then the kids are too sleepy to concentrate the next day. 

This sleep pattern leads to the circadian rhythm disturbances (getting days and nights mixed up, in a way) described by Kooij. Of course, the discipline problems in the houses of these kids are hardly limited to bedtime. Inconsistent, abusive, and/or just plain absent discipline lead to children acting out. You know, “oppositional defiant disorder” and “conduct disorder.” Like I said, acting out.

Thursday, January 3, 2013

ADHD: More Misleading Propaganda




In the never ending effort to con the world in general, and physicians in particular, into thinking that most inattentive and rambunctious children and adults have a neurobiological disease, a Dr. Samuele Cortese and his colleagues presented yet another MRI study that they allege shows that children and adults who have been diagnosed with ADHD have abnormalities in their brains. 

Dr. Cortese is listed as a consultant for Shire Pharmacueticals, a major manufacturer of stimulant drugs for “ADHD.” Or as some might say in ordinary language, Shire is a drug dealing syndicate. One of the most egregious examples of same, at that. Shire’s interests are served by having the largest number of people taking their “legal” amphetamines as possible, while also spreading the word that their competition, “illegal” amphetamines, are dangerous and highly abused drugs.

I use the word “diagnosed” with ADHD in the first paragraph above rather than “have” ADHD because, as I have demonstrated in previous posts, the evaluation of patients who seem to have these problems leaves out an entire and absolutely essential part of their lives – the behavior of their families that provides a context for the child’s “symptoms.” 

No effort, or only a half-baked one, is made in these studies to differentiate acting out from other possible causes for the patient’s hyperactive behavior or difficulties in maintaining focus.

The new study, published in the issue of the American Journal of Psychiatry, proves the following point beyond a shadow of a doubt: people who are not paying good attention to a particular task in which they are engaged exhibit less activity in those brain centers involved in paying attention to tasks than people who are paying strong attention.  Wow. Who’d’a thunk it?

And as we all know, any difference simply must be an abnormality.

In fact, the study says absolutely nothing about whether these research subjects cannot pay attention or simply are not paying attention.

The study in question (Cortese et al, “Toward Systems Neuroscience of ADHD: A Meta-Analysis of 55 fMRI Studies,” Am J Psychiatry 2012; 169:1038-1055) combines statistics from 55 different studies of ADHD, many of which use very different diagnostic “tests” which are merely symptom report lists and pay little attention to the pervasiveness of the symptoms, let alone the psychosocial context in which the symptoms take place.

Here are the results. Hypoactivation is a term meaning that the affected part of the brain is less active, on average, than it might be in a comparison subject. Of course, how active such a brain part might depends strongly on the motivations of the particular subjects. (This is analogous to the results of IQ tests, which are biased against those people who don’t give a damn about how well they do on the test).  Hyperactivation means the opposite.  

Surely, whether more or less activity in a region of the brain is pathological is entirely pre-supposed by the authors without any valid justification. It is basically a value judgment.

“Fifty-five studies were included (39 for children and 16 for adults). In children, hypoactivation in ADHD relative to comparison subjects was observed mostly in systems involved in executive function (frontoparietal network) and at­tention (ventral attentional network). Sig­nificant hyperactivation in ADHD relative to comparison subjects was observed predominantly in the default, ventral at­tention, and somatomotor networks. In adults, ADHD-related hypoactivation was predominant in the frontoparietal system, while ADHD-related hyperactivation was present in the visual, dorsal attention, and default networks. SignificantADHD-related dysfunction largely reflected task features and was detected even in the absence of comorbid mental disorders or a history of stimulant treatment.
Conclusions: A growing literature pro­vides evidence of ADHD-related dysfunc­tion in multiple neuronal systems involved in higher-level cognitive functions but also in sensorimotor processes, including the visual system, and in the default net­work. This meta-analytic evidence extends early models of ADHD pathophysiology that were focused on prefrontal-striatal circuits.”
The studies being "meta-analyzed" are designed on purpose to make it appear that normal differences mean something other than their just being normal differences.
Let us look at the distribution of how strongly people “pay attention” to boring tasks to which they have no particular motivation to do well (other than their desire to be co-operative with an experimenter). Most of the tasks during which brain activity is measured are, let’s face it, at least somewhat uninteresting.
This distribution, like almost everything else in nature, will look like a bell-shaped curve, or what is called normal distribution. We don’t even have to invoke the fact that some people may habitually pay less attention to most activities because they might be compulsively and habitually playing a role ["unambitious"] within their family of origin that allows them to get labeled as having ADHD.

The self report instruments and diagnostic interviews through which a diagnosis of ADHD is made will, in effect, sort the patients so that those labeled with ADHD will fall, on average, at point A on the bell shaped curve in the figure above. Since those individuals will then be taken out of the pool of study subjects, those that remain will have an above average tendency to pay attention to boring tasks – their average will be at point B in the diagram.
Everything else being equal, the “ADHD” subjects and the control control subjects could all be completely normal, and the study result would be identical to a study in which a real disease were being studied! The authors have no way of knowing which of these possibilities their study is demonstrating. They do not clearly acknowledge the above considerations as a weakness of the study, although they do concede, “fMRI data cannot define an absolute or quantitative baseline of activation…” (p. 1053).

That disclaimer is added to give the authors plausible deniability, and will of course be completely ignored by readers if it is noticed at all.
The authors start their discussion of their results with the sentence, “ADHD is increasingly being conceived of as a disorder underpinned by dysfunctions in multiple large scale brain networks.” Yeah, because of pseudo-scientific conclusions made from a multiplicity of studies done the way this one was.

Tuesday, July 10, 2012

Childhood Bipolar Disorder: The View From Abroad




Is Pediatric Bipolar Disorder (PBD) a “culture-bound syndrome” of the USA?

The following is a guest post from Dr. Peter Parry, an Australian psychiatrist and senior lecturer at the University of Queensland, who is a co-conspirator of mine in the fight against the pernicious practice of psychiatrists and pediatricians diagnosing acting-out children as having the major psychiatric disorder bipolar disorder (manic depressive illness).

A “culture-bound syndrome” [http://rjg42.tripod.com/culturebound_syndromes.htm]  in psychiatry is used to describe psychiatric disorders that generally occur in exotic indigenous communities and developing countries due to cultural factors.  Examples include “Koro” - a disorder of group hypochondriasis that occurs in epidemics in parts of south-east Asia where men start to believe that their penises are shrinking into their abdomens; “Dhat” - a disorder in India associated with anxiety and fatigue in men related to fear of losing too much semen; “Bebainan” - a disorder where young women from Balinese nobility, who in everyday life must behave with extreme politeness and be very demure, vent their anger in seemingly irrational brief rage attacks.  The last of these can be seen to have a useful function for individuals whose emotional lives are otherwise highly socially constrained.

In a couple of blog posts on “The Geography of Pediatric Bipolar Disorder” [http://www.psychologytoday.com/blog/your-child-does-not-have-bipolar-disorder] on Psychology Today  I concluded by posing the question: “is Pediatric Bipolar Disorder (PBD) a culture bound syndrome of the USA?”.  As I explained in the first post, PBD, despite becoming the most common diagnosis for pre-pubertal children in US inpatient units 10 years ago [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001259/], has barely rated in the rest of the world. 

This is not to say that there haven’t been a few academic research centers who have investigated PBD in places like Spain, Switzerland, the Netherlands, Brazil, India and Australia.  These research centers have usually collaborated with prominent American PBD research centers such as Prof Biederman’s center at MGH-Harvard.  In clinical practice outside the USA there have been a few isolated pediatricians and rarely child psychiatrists who have adopted the American clinical practice of diagnosing PBD in pre-pubertal children.  But the vast majority of practicing clinicians and academics in child psychiatry and pediatrics in Britain, Europe, Australia, New Zealand and to lesser extent Canada have simply not accepted PBD as a valid diagnostic entity in clinical practice.



Here in Australia, one group that seriously researched the PBD diagnostic constructs was based in Sydney.  Their follow-up research found that few cases went on to true bipolar disorder.  Prof Philip Hazell who led much of this research was quoted in the Australian media [http://www.theaustralian.com.au/news/health-science/moody-teens-wrongly-diagnosed-with-bipolar-disorder-psychiatrist/story-e6frg8y6-1226191879545] saying “There are about 10 times as many people with 'lookalike' mood dysregulation as there are people with bipolar disorder”.

Now it is true that bipolar disorder often first manifests in adolescence and early manic or hypomanic symptoms can be mistaken for extreme adolescent emotionality, risk-taking or substance abuse.  But until an unequivocal manic episode erupts it is difficult to make the diagnosis.  The “BCOS study” [http://www.jad-journal.com/article/S0165-0327(07)00047-X/abstract] was a study of 240 adults mostly in their 40s with classical Bipolar-I or Schizoaffective Disorder in Melbourne and Geelong in Australia.  The BCOS study found that the diagnosis was often made years late.  The study asked the adults when their symptoms first began.  The median age of onset for the first hypomanic/manic episode was 24.1 years old.



Yes bipolar disorder is a severe mental disorder that needs to be detected earlier in life than it often is.  But it is still a disorder that doesn’t usually start until late adolescence or young adulthood.

Another study that asked middle aged adults with bipolar-disorder when they thought their first symptoms of bipolar disorder began was published in the British Journal of Psychiatry [http://www.jad-journal.com/article/S0165-0327(07)00047-X/abstract].  The authors of this study were quite favorably disposed towards PBD.  The remarkable aspect of the study is the discrepancy in recall of symptom onset between the European subjects with adult bipolar disorder (Dutch and Germans) and the American subjects.



Is there something about childhood in the USA that brings on a severe psychotic mental disorder such as bipolar disorder so much earlier than in other countries?  Or is there simply an over-diagnosis fad in operation, one that colors the memory recall of childhood?  Notably the American adults in this study had features more suggestive of milder “bipolar” and more personality and substance use problems than the Europeans who had more classic euphoric manic symptoms.

A 20 year follow-up study [http://www.jaacap.com/article/S0890-8567(09)64566-4/abstract] in New Zealand (NZ) was published in the Journal of the American Academy of Child & Adolescent Psychiatry in 1991 (before the creation of the PBD phenomenon).  It was based on all inpatient admissions to the child and adolescent psychiatric ward for a catchment area of 1 million people.  In those 20 years there were 59 children under age of 18 who presented with a confirmed psychotic illness that included schizophrenia, schizoaffective disorder or mania/bipolar disorder.  Age of diagnosis was based on reports of first symptoms, not date of admission to the inpatient unit.  Of these 59 children and teenagers, only 3 were aged 12 or under at onset of symptoms.  One of these 3 children was reported to have had their first manic episode at age 9, the youngest who later turned out to have schizophrenia was aged 7 at onset of first symptoms.

The lead author of the study is now Emeritus Professor of Child & Adolescent Psychiatry in Auckland, NZ, Prof John Werry.  In a survey that I and colleagues organized of Australian and New Zealand (ANZ) child psychiatrists [http://onlinelibrary.wiley.com/doi/10.1111/j.1475-3588.2008.00505.x/abstract] on PBD that found high levels of skepticism (including that only 3% thought that PBD was not over-diagnosed in the USA), Prof Werry sent a hard hitting comment for public airing:

“I do not see any juvenile bipolar disorder below adolescence and I think that the American view is mostly nonsense as do many of my American colleagues.”

The second author of the NZ study was one of his “American colleagues”, Dr Jon McClellan, a child & adolescent psychiatrist who returned to the USA and is based in Seattle.  Dr McClellan was one of the very few child psychiatrists to have a dissenting article [http://www.jaacap.com/article/S0890-8567(09)61468-4/abstract] on PBD published in the Journal of the American Academy of Child & Adolescent Psychiatry.  With regard to PBD his article concluded:
“the rate of psychotropic agents being prescribed to preschoolers is skyrocketing…Labelling tantrums as a major mental illness lacks face validity and undermines credibility in our profession.”
One very prominent US psychiatrist, Prof Allen Frances who was chair of the DSM-IV task force, has called PBD a “fad” [http://www.psychiatrictimes.com/bipolar-disorder/content/article/10168/1551005] diagnosis.

What I found when attending the American Academy of Child & Adolescent Academy (AACAP) meeting in Hawaii in 2009 is that Werry, McClellan and Frances were spot on.  Many US child psychiatrists were very troubled by the PBD diagnostic fad, the bad effects on the children and families of a spurious diagnosis and wrong treatment, and the undermining of credibility in our profession.  I received mainly supportive comments from my US colleagues when I presented my poster of our Australian and New Zealand survey showing high levels of skepticism about PBD in ANZ.  These comments helped to explain what it was about the culture of the USA that had spawned the PBD fad epidemic.

Firstly – the US health system is mainly a private insurance system and much more fragmented than the universal health cover that exists in nearly all other 30 developed nations in the OECD [http://www.oecd.org/dataoecd/24/8/49084488.pdf].  US health insurers are more likely to restrict reimbursements on the basis of diagnosis than health insurers in other countries.  Also pharmacotherapy is favored over the psychotherapies. 

At the Hawaii AACAP conference an American child psychiatrist told me that if she is seeing a boy with emotional and behavioral problems embedded in difficult family dynamics, with some insurers she has to phone the insurer in the first session and is asked to give a diagnosis. If she says she has no diagnosis at that early stage, the insurance clerk says no reimbursement. If she says the diagnosis is a “parent-child relational problem” (which is a non Axis I DSM diagnosis) she may also be told no reimbursement. If she says it is an “adjustment disorder” (an Axis I DSM diagnosis) then she may be allowed 1 or 2 sessions to fix the complex problems. But if she says it is “bipolar disorder” then ongoing sessions are likely to be reimbursed. 

This is effectively diagnosis by medically untrained health insurance clerk.  It is also an expensive system, the USA spends 17% of its GDP on health care whereas other OECD nations spend between 8% and 11%.  A lot of money goes into paying medically untrained clerks and profits to shareholders.

Secondly the pharmaceutical industry has focused its influence on medical research and public opinion more in the USA than elsewhere.  The pharmaceutical industry is globally the most profitable industry on the planet.  In 2002 the 10 Pharma companies in the Fortune 500 had greater profits than the other 490 world’s biggest companies combined.  In 2008 they averaged 18% profits whilst the rest averaged 0.9% profits in the global recession.  Pharma spend 3 times as much on marketing to the medical profession and (mainly in the USA) the public than they do on Research and Development.  The biggest market for medications, particularly psychotropics, is the USA and direct to consumer advertising (DTCA) is only legal in the USA and New Zealand (but NZ has a tiny market).  Thus the American public have been flooded with advertising of psychotropic drugs and often ads about bipolar disorder whereas the public in other nations have not (though the internet is changing this).

Another US child psychiatrist colleague told me at the ANZ child psychiatry conference in 2007 that in working as a locum in NZ he had never had parents come to see him stating their child had “such and such diagnosis” and demanding a related medication, rather they asked him what he thought.   Conversely parents invariably were fixated on a diagnosis and drug or two when they came to consult him in the USA.  He had also trained at an academic child psychiatric unit prominent in PBD research and was trained to ask himself “is it bipolar?” and diagnosed half a dozen cases of PBD, yet in NZ he’d never seen a case of PBD and had started to question his training.

The pharmaceutical industry provides considerable funding to researchers and to academics to provide “continuing medical education” (CME) to other doctors.  Internal industry documents [http://www.healthyskepticism.org/global/news/int/hsin2009-12] revealed that Pharma saw broadening of bipolar diagnoses in adults and children as useful to selling more atypical antipsychotic agents.  Such CME is a global phenomenon and has been harshly criticized [http://www.psychiatrictimes.com/display/article/10168/1570483] in recent years.  However proponents of PBD providing CME were mainly confined to the USA.

A key researcher in neuroimaging children diagnosed with PBD, Dr Mani Pavuluri, presented findings at the Hawaii AACAP meeting.  The research appeared to be of high technical quality.  The findings (overactive right amygdale, underactive right frontal lobe) were identical to findings in children who had suffered attachment trauma and abuse.  I and others in the audience asked why not call such children “affect dysregulated” rather than PBD.  Dr Pavuluri agreed that would be a more neutral term, but stated “if we don’t call them bipolar we don’t get funding for our research”.  Such a dependence on a presumed result favored by funders reverses the scientific process.

Also at the AACAP Hawaii conference I asked Dr Melissa DelBello about attachment trauma in her group’s research, the interchange was recorded by Dr. David Allen on this blog here [http://davidmallenmd.blogspot.com.au/2010/04/attachment-latest-dirty-word-in.html].

I did an extensive review [http://cdn.intechopen.com/pdfs/29393/InTech-Paediatric_bipolar_disorder_are_attachment_and_trauma_factors_considered_.pdf ] of the PBD literature for exploration of attachment, trauma and abuse as possible contextual factors and found that the PBD literature was extremely lacking in consideration of these very obvious markers of distress in childhood. 

Why this is so is a very interesting question.  Denial and repression of trauma is a feature of humanity, be it at individual, family or societal levels.  Whether this is more the case in the USA is unlikely but it is possible that American parents have been more indoctrinated with the neurobiological paradigm for children’s behavioral problems and this helps them avoid “parent blaming”.  As an aside, I find it helpful to discuss with parents how parenting in modern societies is incredibly difficult compared to how parenting evolved in small hunter-gatherer ancestor tribes. 

But other modern societies have similar epidemics to the US PBD epidemic.  Instead of PBD in Europe, Canada and Australasia there is a tendency to also over-diagnose autistic spectrum disorders and ADHD as ways of overlooking more complicated attachment, trauma, family dynamic, learning difficulties, bullying and other contextual problems.  To a great extent I think the simplistic checklist approach to diagnosis fostered since DSM-III plays a role in this [http://www.clinicalpsychiatrynews.com/views/commentaries/single-article/diagnostic-labels-and-kids-a-call-for-context/5783d363fe823984bafbef98b0ffaa75.html]

According to DSM-IV: “Not all (culture-bound syndromes) are considered pathological in their society of origin, and may be seen as "idioms of distress”, a way of communicating distress in a way which is culturally understood and, to varying degrees, accepted.”  Thus for a society that has been “educated” to see mental, emotional and behavioral problems as based in neurochemistry fixable with medications, where “parent blaming” is considered unsociable, where health insurers value pharmacotherapy over more talking therapies and insurance clerks request more serious diagnoses from clinicians before reimbursing sessions, and where funding of research comes largely from pharmaceutical companies – to diagnose the moodiness and rages of distressed toddlers, preschoolers and older children as bipolar disorder has to varying degrees become accepted. 

Prescribing polypharmacy psychotropic cocktails to toddlers can be seen as the ultimate in a Huxleyan “brave new world”, the ultimate end point of “Pharmageddon” [http://www.socialaudit.org.uk/60700716.htm].  The recent book by Dr David Healy expands on how we arrived at such a point [http://www.ucpress.edu/book.php?isbn=9780520270985].  PBD can also be seen as an emblematic diagnosis for an era of “mindless psychiatry” [http://www.tandfonline.com/doi/pdf/10.1080/15299732.2011.597826].

The US is not alone to suffer from these factors, but it seems to suffer more than other jurisdictions and hence PBD can be seen as a culture bound syndrome of the USA.  That is not to say it couldn’t spread to other nations if the same predisposing factors were to arise, and ADHD and Autistic Spectrum Disorders do to some extent represent a similar phenomena outside the USA.


Saturday, July 23, 2011

Practice of Doping up Children to Treat Parental Anxiety Continues to Grow

I have already written several posts about the inappropriate "diagnosing" of bipolar disorder in children and the even more inappropriate use of antipsychotic medications in children.  My main point has been that, rather than having a psychiatric disorder, the vast majority of these children are just acting out.  (For those readers who have difficulty making distinctions - especially those who automatically assume that things that look vaguely alike must be identical - this opinion does NOT apply to those uncommon children who are actually psychotic or to older adolescents who are clearly and obviously manic).


So what proof can I offer?  Well, at the American Psychiatric Association Annual Meeting, John Goethe, MD (director of the Burlingame Center for Psychiatric Research and Education at Hartford Hospital’s Institute of Living), presented the results of a decade-long study of antipsychotic prescribing for children and adolescents in psychiatric hospitals.

The results? Forty-five percent of patients with such behavioral disorders as ADHD or conduct disorder were given antipsychotics and 44% of patients with post-traumatic stress disorder (PTSD) received them. The percentage for other anxiety disorders was 31%!

Forgetting for the moment that an ADHD diagnosis may just be yet another case of acting out, antipsychotic medication is not indicated for ADHD.  In adults, antipsychotic medications are not indicated nor FDA-approved for any anxiety disorder or PTSD.  Not only that, but there is not the slightest evidence from any neurobiological study that the purported mechanism of action of antipsychotic medication has anything to do with anxiety disorders or ADHD. 

And conduct disorder?  This "disorder" was formerly called juvenille delinquincy.  Acting out by any other name. Don't even get me started.

One of the predominant side effects of these medications, is however, sedation.  So one might conclude that the reason the meds seem to both the parents and incompetent doctors to "work" is that the kids quiet down because they are being doped up. (This prescribing practice does not just apply to some psychiatrists but also to many other primary care doctors as well -as to pediatricians, read Claudia Gold's blogpost, Pediatricians Prescribing Psychiatric Medication: A Dose of Reality),

But who's anxiety is really being treated here? 

I submit that it is the anxiety of the parents. Parents who have out-of-control, acting-out children are the real objects of these "treatments."  These parents covertly feel guilty when they are unable to control their children due to inconsistent, neglectful, or abusive parenting practices.  Yet they have great difficulty changing these practices for a variety of reasons - sometimes very understandable reasons.  (One of which is that their doctors make no effort to understand what is really going on in their homes, and take advantage of their insecurities). 

Nonetheless, when the kids are doped up and are therefore less trouble, the parents feel better. And they have the doctors stamp of approval that the problem resides entirely within the child, not with them.

An unsolicited plug

The use of these drugs in kids diagnosed with PTSD is particularly instructive.  Unless you are treating victims of such disasters as the recent outbreak of tornadoes in the South and Midwest, or working with victims of crime like Jaycee Dugard, the most common trauma leading to PTSD in children is child abuse.

Of course, this whole process of sedating acting-out children usually does not end with the first prescription.  For most drugs that have sedation as a side effect, the sedation gradually subsides after  a few weeks on the medication.  Then, of course, the kid starts doing what kids always do - start reverting back to their previous behavior.

The parents then drag him or her back to the incompetent doctor, who starts to take one of the following steps and then another, in no particular order:
  1. Increase the dose of the medication.
  2. Change to a different medication which also is not indicated for anxiety and conduct disorders.
  3. Add a prescription for a second one of those medications, and then perhaps a third or a fourth.
  4. Change the diagnosis to something else other than acting out, and begin the whole process all over again.
Since the kid still is not controlled after the sedative side effect subsides, another step the parents can take is to apply for social security disability for the child.  This gives the child the message that the parents think he or she is both sick and incompetent.

Readers of the blog know what I believe happens next.  The child develops a false self that only seems to be sick and incompetent.  Such children hide their abilities as they grow into adults, continue to act in ways that preclude employment, and continue on social security disability. 

When you take the time to actually get to know them, however, it seems that the only thing they can not seem to do that most people can is maintain employment.

And then Robert Whitaker thinks that the medications were the cause of the disability, just like the less-than-thorough doctors thought that the medications caused the initial improvement of the child's "mental illness" when it was just a side effect that temporarily muted acting out behavior. 

It always amazes me how much people who seem to be on opposite sides of a debate think alike.  Basing their conclusions on totally incomplete information seems to be a favorite blind spot of theirs.

Saturday, November 13, 2010

None Dare Call it Acting Out

Recent headline (November 11, 2010) in the Memphis Commercial Appeal newpaper:  "Survey: 1 in 10 U.S. children has ADHD."  One in ten.  Imagine that!  "Biological" psychiatrists believe that ADHD is a genetic and/or neurodevelopmental disorder.  I can't think of any other such disorder that effects 10% of the entire population.

The survey was performed by the U.S. Goverment.  According to the newspaper article, this represents a "sizable increase from a few years earlier that might be explained by growing awareness and better screening."  Specifically, the number represents an increase of 22% from 2003 to 2007.  The actual numbers of affected kids would be 5.4 million children - an increase of about one million in that period of time. Two thirds of the children were on medication.

Of course, the study seemed to just assume that the diagnoses were all valid.  Surely there are more parents aware of ADHD than ever before, so the "increased awareness" part of the story is undoubtedly true. 

The statistics for the "incidence" of childhood bipolar disorder (also called pediatric bipolar) are even more striking.  Prescriptions for powerful psychiatric drugs to young children for this disorder quintupled in less than four years.  The graph below shows the amazing increase in private office visits for bipolar disorder in children under twenty. 

Source: Pharmed Out

Of course, real bipolar disorder often first manifests in sufferer's late teens, and rarely occurs in children - as reflected in the number of office visits shown in '94-95, before pediatric bipolar diagnosis became a fad.  For decades, the incidence of bipolar disorder was pegged at about 1%, but now suddenly it is almost 5%.  This figure includes many who are diagnosed as "bipolar II" or "bipolar NOS" (see my post of July 24, 2010, Counting Symptoms that Don't Count for a discussion of how the designation NOS has been misused in defining bipolar disorder).

The dramatic increase in diagnosis of both ADHD and pediatric bipolar (without any change in the gene pool) is more strong evidence for the main thesis of my book, How Dysfunctional Families Spur Mental Disorders.  An upspoken and unholy alliance between pharmaceutical companies, biological psychiatrists, and overwhelmed and guilty parents has led to the disappearance in many mental health circles of the use of the term acting out in children in favor of a brain disease model for out-of-control children. 

As defined by Psychcentral.com, acting out is performing an extreme behavior in order to express thoughts or feelings the person feels incapable of otherwise expressing. Instead of saying, “I’m angry with you,” a person who acts out may instead throw a book at the person, or punch a hole through a wall. When a person acts out, it can act as a pressure release, and often helps the individual feel calmer and peaceful once again. For instance, a child’s temper tantrum is a form of acting out when he or she doesn’t get his or her way with a parent. Self-injury may also be a form of acting-out, expressing in physical pain what one cannot stand to feel emotionally.

Heaven forbid we should look at the problematic parenting trends described in detail by parenting columnist John Rosemond or the staggering incidence of child abuse and neglect in creating acting out.  How much more comforting for parents to think they bear no responsibility for how their children turn out.